Toona Sinensis Extracts Induced Cell Cycle Arrest and Apoptosis in the Human Lung Large Cell Carcinoma

Kaohsiung Journal of Medical Sciences

Volumn 26, Issue 2, 2010, Pages 68-75

  Wang, Cheng Yuan ^a   Lin, Kai Huang ^b   Yang, Chih Jen ^a,d   Tsai, Jong Rung ^a,d   Hung, Jen Yu ^a,d   Wang, Pei Hui ^a   Hsu, Hseng Kuang ^c   Huang, Ming Shyan ^a,d  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b Department of Internal Medicine   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

apoptosis; cell cycle; lung cell carcinoma; Toona sinensis

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; PLANT EXTRACT; PROTEIN P27; TOONA SINENSIS EXTRACT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL SURVIVAL; CELL VIABILITY; DNA DEGRADATION; DOSE TIME EFFECT RELATION; DRUG SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; LARGE CELL CARCINOMA; PLANT LEAF; PROTEIN EXPRESSION; WESTERN BLOTTING;

APOPTOSIS; CARCINOMA, LARGE CELL; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HUMANS; LUNG NEOPLASMS; MELIACEAE; PLANT EXTRACTS;

EID: 76749108082     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1607-551X(10)70010-3     Document Type: Article

References (45)

1. Carney D.N. Lung cancer-time to move on from chemotherapy. N Engl J Med 346 (2002) 126-128
2. García-Yuste M., Matilla J.M., and González-Aragoneses F. Neuroendocrine tumors of the lung. Curr Opin Oncol 20 (2008) 148-154
3. Zacharias J., Nicholson A.G., Ladas G.P., et al. Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic nodal dissection. Ann Thorac Surg 75 (2003) 348-352
4. Rylander R., and Axelsson G. Lung cancer risks in relation to vegetable and fruit consumption and smoking. Int J Cancer 118 (2006) 739-743
5. Voorrips L.E., Goldbohm R.A., Verhoeven D.T., et al. Vegetable and fruit consumption and lung cancer risk in the Netherlands Cohort Study on Diet and Cancer. Cancer Causes Control 11 (2000) 101-115
6. Sankaranarayanan R., Varghese C., Duffy S.W., et al. A case-control study of diet and lung cancer in Kerala, South India. Int J Cancer 58 (1994) 644-649
7. Nyberg F., Agrenius V., Svartengren K., et al. Dietary factors and risk of lung cancer in never-smokers. Int J Cancer 78 (1998) 430-436
8. Arab L., Steck-Scott S., and Fleishauer A.T. Lycopene and the lung. Exp Biol Med 227 (2002) 894-899
9. Sun A.S., Ostadal O., Ryznar V., et al. Phase I/II study of stage III and IV non-small cell lung cancer patients taking a specific dietary supplement. Nutr Cancer 34 (1999) 62-69
10. Sun A.S., Yeh H.C., Wang L.H., et al. Pilot study of a specific dietary supplement in tumor-bearing mice and in stage IIIB and IV non-small cell lung cancer patients. Nutr Cancer 39 (2001) 85-95
11. Edmonds J.M., and Staniforth M. Toona sinensis. Curtis' Bot Mag 15 (1998) 186-193
12. Chang H.C., Hung W.C., Huang M.S., et al. Extract from the leaves of Toona sinensis roemor exerts potent anti-proliferative effect on human lung cancer cells. Am J Chin Med 30 (2002) 307-314
13. Fan S., Chen H.N., Wang C.J., et al. Toona sinensis Roem (Meliaceae) leaf extract alleviates liver fibrosis via reducing TGFbeta1 and collagen. Food Chem Toxicol 45 (2007) 2228-2236
14. Chang H.L., Hsu H.K., Su J.H., et al. The fractionated Toona sinensis leaf extract induces apoptosis of human ovarian cancer cells and inhibits tumor growth in a murine xenograft model. Gynecol Oncol 102 (2006) 309-314
15. Yang H.L., Chang W.H., Chia Y.C., et al. Toona sinensis extracts induces apoptosis via reactive oxygen species in human promyelocytic leukemia cells. Food Chem Toxicol 44 (2006) 1978-1988
16. Hseu Y.C., Chang W.H., Chen C.S., et al. Antioxidant activities of Toona sinensis leaves extracts using different antioxidant models. Food Chem Toxicol 46 (2008) 105-114
17. Liao J.W., Chung Y.C., Yeh J.Y., et al. Safety evaluation of water extracts of Toona sinensis Roemor leaf. Food Chem Toxicol 45 (2007) 1393-1399
18. Liu L.F., Liang C.H., Shiu L.Y., et al. Action of solamargine on human lung cancer cells: enhancement of the susceptibility of cancer cells to TNFs. FEBS Lett 577 (2004) 67-74
19. Liang C.H., Shiu L.Y., Chang L.C., et al. Solamargine enhances Her2 expression and increases the susceptibility of human lung cancer H661 and H69 cells to trastuzumab and epirubicin. Chem Res Toxicol 21 (2007) 393-399
20. Yang G.Y., Liao J., Kim K., et al. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 19 (1998) 611-616
21. Scudiero D.A., Shoemaker R.H., Paull K.D., et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48 (1988) 4827-4833
22. Ohmori T., Podack E.R., Nishio K., et al. Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by BCL2. Biochem Biophys Res Commun 192 (1993) 30-36
23. Sun S.Y., Yue P., Zhou J.Y., et al. Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells. Biochem Biophys Res Commun 280 (2001) 788-797
24. Nguewa P.A., Fuertes M.A., Alonso C., et al. Pharmacological modulation of poly(ADP-ribose) polymerase-mediated cell death: exploitation in cancer chemotherapy. Mol Pharmacol 64 (2003) 1007-1014
25. Ratschiller D., Heighway J., Gugger M., et al. Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival. J Clin Oncol 21 (2003) 2085-2093
26. Wang J., Miao L.J., Wu Y.M., et al. Expression of AKT2, cyclin D1, and MMP-9 and their correlations to clinicopathologic features of non-small cell lung cancer. Chin J Cancer 25 (2006) 69-72
27. Keum J.S., Kong G., Yang S.C., et al. Cyclin D1 over-expression is an indicator of poor prognosis in resectable non-small cell lung cancer. Br J Cancer 81 (1999) 127-132
28. Caputi M., Groeger A.M., Esposito V., et al. Prognostic role of cyclin D1 in lung cancer. Relationship to proliferating cell nuclear antigen. Am J Respir Cell Mol Biol 20 (1999) 746-750
29. Nguyen V.N., Mirejovsky P., Mirejovsky T., et al. Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and BCL2. Acta Histochem 102 (2000) 323-338
30. Kawamata N., Miller C.W., and Koeffler H.P. Molecular analysis of a family of cyclin-dependent kinase inhibitor genes (p15/MTS2/INK4b and p18/INK4c) in non-small cell lung cancers. Mol Carcinog 14 (1995) 263-268
31. Esposito V., Baldi A., De Luca A., et al. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 57 (1997) 3381-3385
32. Ishihara S., Minato K., Hoshino H., et al. The cyclin-dependent kinase inhibitor p27 as a prognostic factor in advanced non-small cell lung cancer: its immunohistochemical evaluation using biopsy specimens. Lung Cancer 26 (1999) 187-194
33. Zhou B.S., and Elledge S.J. The DNA damage response: putting checkpoints in perspective. Nature 408 (2000) 433-439
34. Shivapurkar N., Reddy J., Chaudhary P.M., et al. Apoptosis and lung cancer: a review. J Cell Biochem 88 (2003) 885-898
35. Jiang S.X., Sato Y., Kuwao S., et al. Expression of BCL2 oncogene protein is prevalent in small cell lung carcinomas. J Pathol 177 (1995) 135-138
36. Kitagawa Y., Wong F., Lo P., et al. Overexpression of BCL2 and mutations in p53 and K-ras in resected human non-small cell lung cancers. Am J Respir Cell Mol Biol 15 (1996) 45-54
37. Walker C., Robertson L., Myskow M., et al. Expression of the BCL2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas. Br J Cancer 72 (1995) 164-169
38. Pezzella F., Turley H., Kuzu I., et al. BCL2 Protein in non-small-cell lung carcinoma. N Engl J Med 329 (1993) 690-694
39. Lindahl T., Satoh M.S., Poirier G.G., et al. Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem Sci 20 (1995) 405-411
40. D'Amours D., Desnoyers S., D'Silva I., et al. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 342 (1999) 249-268
41. Paterson J., Uriel C., Egron M.J., et al. Antiproliferative and apoptotic activities of ketonucleosides and ketoc-glycosides against non-small-cell lung cancer cells with intrinsic drug resistance. Antimicrob Agents Chemother 42 (1998) 779-784
42. Khan Q.A., and Anderson L.M. Hydrocarbon carcinogens evade cellular defense mechanism of G1 arrest in non-transformed and malignant lung cell lines. Toxicol Appl Pharmacol 173 (2001) 105-113
43. Stuschke M., Sak A., Wurm R., et al. Radiation-induced apoptosis in human non-small-cell lung cancer cell lines is secondary to cell-cycle progression beyond the G2-phase checkpoint. Int J Radiat Biol 78 (2002) 807-819
44. Shapiro G.I., Park J.E., Edwards C.D., et al. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res 55 (1995) 6200-6209
45. Lee J.H., Lee C.T., Yoo C.G., et al. The inhibitory effect of adenovirus-mediated p16INK4a gene transfer on the proliferation of lung cancer cell line. Anticancer Res 18 (1998) 3257-3261